Cargando…

Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons

Existing treatment modalities for Graves’ disease includes antithyroid drugs (ATDs), radioactive iodine, and surgery. There has been a lack of general agreement as to which therapy is the best as none is ideal since all effectively restore euthyroidism, but with some limitations. Previously, therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajput, Rajesh, Goel, Vasudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830376/
https://www.ncbi.nlm.nih.gov/pubmed/24251229
http://dx.doi.org/10.4103/2230-8210.119513
_version_ 1782291488780058624
author Rajput, Rajesh
Goel, Vasudha
author_facet Rajput, Rajesh
Goel, Vasudha
author_sort Rajput, Rajesh
collection PubMed
description Existing treatment modalities for Graves’ disease includes antithyroid drugs (ATDs), radioactive iodine, and surgery. There has been a lack of general agreement as to which therapy is the best as none is ideal since all effectively restore euthyroidism, but with some limitations. Previously, therapies were selected with the goal of achieving euthyroidism. Instead, hypothyroidism is now the goal of treatment, to ensure that hyperthyroidism does not recur. Current evidences suggest that high relapse rate and not so rare fatal side effects seen with ATD therapy compel one to consider other definite modes of treatment like radiotherapy and surgery for toxic Graves’ disease after discussing this with the patient.
format Online
Article
Text
id pubmed-3830376
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38303762013-11-18 Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons Rajput, Rajesh Goel, Vasudha Indian J Endocrinol Metab Review Article Existing treatment modalities for Graves’ disease includes antithyroid drugs (ATDs), radioactive iodine, and surgery. There has been a lack of general agreement as to which therapy is the best as none is ideal since all effectively restore euthyroidism, but with some limitations. Previously, therapies were selected with the goal of achieving euthyroidism. Instead, hypothyroidism is now the goal of treatment, to ensure that hyperthyroidism does not recur. Current evidences suggest that high relapse rate and not so rare fatal side effects seen with ATD therapy compel one to consider other definite modes of treatment like radiotherapy and surgery for toxic Graves’ disease after discussing this with the patient. Medknow Publications & Media Pvt Ltd 2013-10 /pmc/articles/PMC3830376/ /pubmed/24251229 http://dx.doi.org/10.4103/2230-8210.119513 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Rajput, Rajesh
Goel, Vasudha
Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
title Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
title_full Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
title_fullStr Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
title_full_unstemmed Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
title_short Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
title_sort indefinite antithyroid drug therapy in toxic graves’ disease: what are the cons
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830376/
https://www.ncbi.nlm.nih.gov/pubmed/24251229
http://dx.doi.org/10.4103/2230-8210.119513
work_keys_str_mv AT rajputrajesh indefiniteantithyroiddrugtherapyintoxicgravesdiseasewhatarethecons
AT goelvasudha indefiniteantithyroiddrugtherapyintoxicgravesdiseasewhatarethecons